Brief: Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
25/11/2024 13:16
Nov 25 (Reuters) - Allurion Technologies Inc ALUR.N :
* ALLURION LAUNCHES IN THE US WITH ITS FIRST AI-NATIVE
COMPOUNDED
GLP-1 PROGRAM
Source text: ID:nBw7TZkhYa
Further company coverage: ALUR.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allurion Technologies
See all newsBrief: Allurion Technologies Inc - Sees Growing Demand From Patients Discontinuing Glp-1 Therapy
Brief: Allurion Intends To Appeal NYSE Notice Of Delisting, Execute Plan To Regain Compliance, And Expects To Continue Trading On NYSE
Brief: NYSE To Commence Delisting Proceedings Against Allurion Technologies, Inc.
Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina
Allurion rises after strong weight-loss data from combination therapy